Vericel 
Welcome,         Profile    Billing    Logout  
 3 Products   2 Diseases  3 Products   2 Trials   952 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MACI (matrix-induced autologous chondrocyte implant) / Vericel
MASCOT, NCT06915233: A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Not yet recruiting
3
276
NA
autologous cultured chondrocytes on porcine collagen membrane, Bone Marrow Stimulation
Vericel Corporation
Chondral Defect, Articular Cartilage Defect
02/30
02/30
PEAK, NCT03588975: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Recruiting
3
45
US
MACI, microfracture
Vericel Corporation
Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
06/27
06/27
ixmyelocel-t (ixCELL-DCM) / Vericel
2006-001286-42: Multi-center, Multi-national Clinical Trial of the Application of Tissue Repair Cell (TRC) Therapy of Osteonecrosis in the Femur Head

Ongoing
3
5
Europe
Tissue Repair Cells,
Aastrom Biosciences, Inc
Osteonecrosis of the femur head
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MACI (matrix-induced autologous chondrocyte implant) / Vericel
MASCOT, NCT06915233: A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Not yet recruiting
3
276
NA
autologous cultured chondrocytes on porcine collagen membrane, Bone Marrow Stimulation
Vericel Corporation
Chondral Defect, Articular Cartilage Defect
02/30
02/30
PEAK, NCT03588975: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Recruiting
3
45
US
MACI, microfracture
Vericel Corporation
Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
06/27
06/27
ixmyelocel-t (ixCELL-DCM) / Vericel
2006-001286-42: Multi-center, Multi-national Clinical Trial of the Application of Tissue Repair Cell (TRC) Therapy of Osteonecrosis in the Femur Head

Ongoing
3
5
Europe
Tissue Repair Cells,
Aastrom Biosciences, Inc
Osteonecrosis of the femur head
 
 

Download Options